Trade Centessa Pharmaceuticals Limited - CNTA
Centessa Pharmaceuticals Limited (NASDAQ: CNTA) is a U.K.-based biotech company operating a unique decentralized R&D model across multiple subsidiaries targeting rare and specialty diseases. Its pipeline includes candidates in hematology, immunology, and oncology, with a focus on asset-centric development efficiency. Backed by life sciences investors, Centessa aims to streamline drug discovery while de-risking capital deployment. It offers investors a diversified, early-stage biotech platform with program-level optionality and clinical momentum.Latest shares articles

What you need to know about Alphabet after the biggest one-day drop in its history – break-down
Google Cloud is growing fast, but AI spending pushed Alphabet’s free cash flow negative. A full break-down of results, valuation, debt and risks for GOOGL
11:53, 13 November 2026

Amazon's USD 220bn bet: how record AI spending could reshape the company
Amazon plans about USD 220bn of capex in 2026. We look at AWS, profitability, debt, valuation and the key catalysts and risks for AMZN shares.
10:50, 6 November 2026

US midterms: the end of uncertainty could give Wall Street direction
Markets dislike uncertainty and volatility tends to rise ahead of the vote, but once the results are known, indices may be able to set a clearer direction.
13:28, 29 October 2026

BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026